Literature DB >> 12752555

Nasal neutrophil activity and mucinous secretory responsiveness in COPD.

Ulf Nihlén1, Morgan Andersson, Claes-Göran Löfdahl, Carl G A Persson, Peter Montnémery, Lennart Greiff.   

Abstract

Patients with chronic obstructive pulmonary disease (COPD) frequently report nasal symptoms. In the present study, we have examined whether or not COPD is associated with any nasal inflammation. Plasma exudation evoked by histamine challenges has been employed to improve the recovery of inflammatory indices in nasal lavage fluids. In 23 COPD-patients and 26 healthy subjects, all without history or signs of allergic rhinitis, nasal polyposis, or chronic rhinosinusitis, nasal saline-lavages were performed with and without histamine. alpha2-Macroglobulin, fucose, eosinophil cationic protein (ECP) and myeloperoxidase (MPO) were determined as indices of plasma exudation, mucinous secretion, eosinophil activity and neutrophil activity, respectively. The difference in MPO-levels between the histamine and the saline lavage was greater in COPD patients compared with healthy subjects (P<0.05). Also, COPD patients reporting nasal symptoms presented an increase in MPO at histamine challenge (P<0.05, cf. saline) and greater differences in MPO and fucose, respectively, between the histamine and the saline lavage (P<0.05, cf. patients without symptoms). We conclude that COPD is not associated with any marked nasal inflammation. However, our observation on increased MPO-levels at histamine challenge suggests some degree of increased neutrophil activity in this condition. Furthermore, when associated with nasal symptoms, COPD may be associated with an increased nasal secretory responsiveness.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12752555     DOI: 10.1046/j.1475-097x.2003.00484.x

Source DB:  PubMed          Journal:  Clin Physiol Funct Imaging        ISSN: 1475-0961            Impact factor:   2.273


  3 in total

1.  Evaluation of IL-8 nasal lavage levels and the effects of nasal involvement on disease severity in patients with stable chronic obstructive pulmonary disease.

Authors:  Hacer Celik; Serdar Akpinar; Hayriye Karabulut; Pinar Oktar; Berna Dursun; Huyla Celenk Erguden; Sibel Gunay; Tugrul Sipit
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

2.  Rhinosinusitis in COPD: symptoms, mucosal changes, nasal lavage cells and eicosanoids.

Authors:  Violetta M Piotrowska; Wojciech J Piotrowski; Zofia Kurmanowska; Jerzy Marczak; Paweł Górski; Adam Antczak
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-06-03

3.  Frequency and effect of type 1 hypersensitivity in patients from India with chronic obstructive pulmonary disease and associated upper airways symptoms.

Authors:  Avi Kumar; Shekhar Kunal; Ashok Shah
Journal:  Asia Pac Allergy       Date:  2017-10-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.